Related Experiment Video
Updated: Jun 5, 2026

Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva
Published on: April 3, 2018
The Effect of Different Gingival Phenotypes on Keratinized Tissue Augmentation Using Xenogeneic Collagen Matrix
Ying-Jie Lin1, Chang Chen2, Rui-Yong Wang1
1Department of Stomatology, Beijing Haidian Hospital, Beijing, China.
Objective:
The xenogeneic collagen matrix (XCM) is widely used for keratinized mucosa augmentation around natural teeth and dental implants due to its consistent efficacy and the advantage of avoiding a second surgical site. This study aimed to investigate the influence of different gingival phenotypes on the effectiveness of XCM in augmenting keratinized mucosa width.
Materials And Methods:
Thirty-two patients with buccal keratinized tissue width (KTW) <2 mm at mandibular molar sites were enrolled and equally divided into two groups (n = 16 each). Based on the keratinized tissue thickness (KTT) measured, patients were assigned to either a thin phenotype group or a thick phenotype group. All underwent XCM-based augmentation, with gingival parameters recorded preoperatively, immediately postoperatively, and at 3- and 6-month follow-ups. KTW, KTT, and the shrinkage rate of KTW were measured.
Results:
No statistically significant differences were observed in preoperative or immediate postoperative KTW between groups (p = 0.598). At 3 and 6 months, the thick phenotype group exhibited significantly greater KTW (5.2 ± 0.67 mm vs. 3.9 ± 0.88 mm, p < 0.001; 4.7 ± 0.68 mm vs. 3.2 ± 0.65 mm, p < 0.001) and lower contraction rates (26.49 ± 7.4% vs. 44.39 ± 11.25%, p < 0.001; 33.49 ± 8.77% vs. 53.5 ± 10.08%, p < 0.001) compared with the thin phenotype group. Changes in KTT following XCM augmentation showed no significant intergroup differences (p = 0.976, p = 0.879).
Conclusion:
XCM yields more predictable outcomes in thick gingival phenotypes than in thin phenotypes for keratinized mucosa augmentation. Over a 6-month period, thick phenotype patients demonstrate significantly reduced material contraction rates.
Clinical Relevance:
The gingival phenotype should be considered when planning keratinized tissue augmentation.
Trial Registration:
Chinese Clinical Trial Registry, no. ChiCTR2500100933 (last updated on 17/04/2025).

